Insider Trading History of Ono Richard Dana

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Ono Richard Dana since 2014. This trader's CIK number is 1595989. At the time of last reporting, Ono Richard Dana was the Officer of Lipocine Inc.. (stock ticker symbol LPCN). Also see all insider trading activities at Lipocine Inc..

Note that in the past Ono Richard Dana also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Inhibitor Therapeutics, Inc. (HPPI) by Ono Richard Dana

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2017 HPPI 0 $0 0 $0 750,000 $0

Yearly summary of insider trading at Lipocine Inc. (LPCN) by Ono Richard Dana

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 LPCN 4,000 $1,360 0 $0 0 $0
2020 LPCN 0 $0 0 $0 5,250 $0
2017 LPCN 0 $0 875 $3,033 1,750 $0
2014 LPCN 4,000 $20,560 0 $0 0 $0


Insider trading activities at 2 companies by Ono Richard Dana:

1. Inhibitor Therapeutics, Inc. (HPPI)

2. Lipocine Inc. (LPCN)

Table 1. Insider trading of Inhibitor Therapeutics, Inc. (HPPI) by Ono Richard Dana

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2017-03-08 HPPI Option Ex 750,000 .00 0

Table 2. Insider trading of Lipocine Inc. (LPCN) by Ono Richard Dana

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-03-20 LPCN Buy 4,000 .34 1,360
2020-12-16 LPCN Option Ex 5,250 .00 0
2017-12-29 LPCN Sale 875 3.47 3,033
2017-12-29 LPCN Option Ex 1,750 .00 0
2014-11-19 LPCN Buy 4,000 5.14 20,560

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ono Richard Dana (Officer of Lipocine Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.